Cadrenal Therapeutics, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Cadrenal Therapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $8,519,250 last year, which is more than in the previous period. 10% of Cadrenal Therapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $826,875, which means an decrease by -87% compared compared to last year.
Debt to Assets
| 2022 | 778174 | 6.32M | 813.36% |
|---|---|---|---|
| 2023 | 8519250 | 826.87K | 9.71% |
CVKD Balance Sheet (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Assets | ||
Current assets: | ||
Cash and cash equivalents | 8.40M | 32.58K |
Short term investments | 0 | 0 |
Net receivables | 0 | 0 |
Inventory | 0 | 0 |
Other current assets | 89.67K | 695.01K |
Total current assets | 8.49M | 727.59K |
Non-current assets: | ||
Property, Plant and Equipment | 23.28K | 44.59K |
Goodwill | 0 | 0 |
Intangible assets | 0 | 0 |
Long term investments | 0 | 0 |
Other non-current assets | 3.79K | -526.01K |
Total non-current assets | 27.07K | 50.57K |
Total assets | 8.51M | 778.17K |
Liabilities | ||
| Current liabilities: | ||
Accounts payable | ||
Deferred revenue | 0 | 0 |
Short term debt | 42.7K | 66.01K |
Total current liabilities | 826.87K | 1.33M |
| Non-current liabilities: | ||
Long term debt | 0 | 574.69K |
Deferred tax | 0 | 0 |
Other non-current liabilities | 0 | 4.42M |
Total non-current liabilities | 0 | 4.99M |
Total liabilities | 826.87K | 6.32M |
| Data source | Data source |